Peptide vs whole protein: which formula boosts absorption in ICU patients?

NCT ID NCT07709611

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial tests whether short peptide enteral nutrition formulas help ICU patients with a high risk of pancreatic exocrine insufficiency absorb protein better than standard whole protein formulas. Researchers will measure amino acid levels and other markers in 250 critically ill adults. The goal is to find the most efficient way to deliver protein to these vulnerable patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
short peptide enteral nutrition formula and whole protein enteral nutrition formula
What this could lead to
If peptide formulas prove better, this could improve protein absorption and recovery for critically ill patients with pancreatic issues.
What could go wrong
This is a single-center trial with 250 participants, so results may not apply broadly. The benefit may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENTERAL NUTRITION FEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai Tongji Hospital

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.